Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

March 29, 2016

MSF urges Indian Prime Minister not to cave into pressure from EU to accept trade deal that could prevent millions of people from accessing lifesaving medicines

March 21, 2016

New York/Geneva, March 21, 2016—Two years after two new drugs to treat tuberculosis (TB)—the first in over 50 years—were conditionally approved for use, only two percent of the 150,000 people who need them most have been able to access them, according to Doctors Without Borders’ new edition of DR-TB Drugs Under the Microscope.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

December 02, 2015

GENEVA/CAPE TOWNDoctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership today released the second edition of the Out of Step report, a 24-country survey of policies and practices used today to guide the diagnosis and treatment of tuberculosis (TB).

March 20, 2015

endTB will provide access to new anti-TB drugs for more than 3,000 people and run clinical trials to identify safer and more effective treatments.

March 19, 2015

Doctors Without Borders and research center in Borstel, Germany, publish findings in New England Journal of Medicine.

October 30, 2014

BARCELONA/NEW YORKOutdated policies and practices and critical gaps in care for drug-resistant tuberculosis (DR-TB) are fueling a worldwide public health crisis, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) in a new report, Out of Step, released today at the 45th Union World Conference on Lung Health.

May 19, 2014

Phumeza Tisile, co-author of the DR-TB Manifesto and XDR-TB survivor, delivers urgent plea to World Health Assembly delegates on behalf of 50,000 supporters worldwide.

March 17, 2014

 

AMSTERDAM/NEW YORKImmediate action is needed from governments, pharmaceutical companies, and researchers to find new treatments for drug-resistant tuberculosis (DR-TB), and to prevent people from dying from one of the world’s most urgent global health threats, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today in a report released in advance of World TB Day.

March 01, 2014

Yangon/New York, March 1, 2014 -- On February 27, Médecins Sans Frontières Holland (MSF) received a written order from the Union Government of Myanmar to cease all operations in the country, which led to a full closure of all MSF Holland clinics on February 28. This act left patients confused and desperately concerned across the whole country.

Pages